Wenlan Dong

1.2k total citations · 1 hit paper
48 papers, 767 citations indexed

About

Wenlan Dong is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Organizational Behavior and Human Resource Management. According to data from OpenAlex, Wenlan Dong has authored 48 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 12 papers in Epidemiology and 8 papers in Organizational Behavior and Human Resource Management. Recurrent topics in Wenlan Dong's work include Cardiovascular Health and Risk Factors (14 papers), Global Public Health Policies and Epidemiology (8 papers) and Healthcare Systems and Public Health (7 papers). Wenlan Dong is often cited by papers focused on Cardiovascular Health and Risk Factors (14 papers), Global Public Health Policies and Epidemiology (8 papers) and Healthcare Systems and Public Health (7 papers). Wenlan Dong collaborates with scholars based in China, Australia and United States. Wenlan Dong's co-authors include Maigeng Zhou, Peng Yin, Shicheng Yu, Xiaohui Xu, Xinwen Ren, Tingling Xu, Xinying Zeng, Maigeng Zhou, Mayinuer Yusufu and Bingsong Wang and has published in prestigious journals such as Pain, Journal of Affective Disorders and British Journal of Ophthalmology.

In The Last Decade

Wenlan Dong

44 papers receiving 758 citations

Hit Papers

Disease burden of Parkinson's disease in China and its pr... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenlan Dong China 10 146 104 97 96 89 48 767
Hongpeng Sun China 21 288 2.0× 126 1.2× 117 1.2× 154 1.6× 205 2.3× 78 1.3k
María Jesús García de Yébenes Spain 22 207 1.4× 119 1.1× 125 1.3× 40 0.4× 128 1.4× 63 1.2k
Sean Harrison United Kingdom 18 248 1.7× 142 1.4× 61 0.6× 56 0.6× 158 1.8× 38 1.1k
Gérard Reach France 22 135 0.9× 182 1.8× 28 0.3× 110 1.1× 136 1.5× 85 1.4k
Suh-Yuh Wu United States 9 156 1.1× 96 0.9× 62 0.6× 331 3.4× 86 1.0× 9 940
Zhongrui Yan China 18 195 1.3× 74 0.7× 89 0.9× 15 0.2× 84 0.9× 53 972
Esther Rubinat Spain 17 95 0.7× 98 0.9× 16 0.2× 156 1.6× 77 0.9× 49 766
Heiner Claessen Germany 16 162 1.1× 88 0.8× 20 0.2× 49 0.5× 95 1.1× 36 862
Christina Bjørk Petersen Denmark 23 97 0.7× 193 1.9× 77 0.8× 37 0.4× 303 3.4× 90 1.3k

Countries citing papers authored by Wenlan Dong

Since Specialization
Citations

This map shows the geographic impact of Wenlan Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenlan Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenlan Dong more than expected).

Fields of papers citing papers by Wenlan Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenlan Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenlan Dong. The network helps show where Wenlan Dong may publish in the future.

Co-authorship network of co-authors of Wenlan Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Wenlan Dong. A scholar is included among the top collaborators of Wenlan Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenlan Dong. Wenlan Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teng, Y K Onno, et al.. (2025). Efficacy and safety of telitacicept in patients with class III–V lupus nephritis: A real-world retrospective cohort study. International Immunopharmacology. 154. 114596–114596. 1 indexed citations
2.
Liu, Tingzhuo, Xinyi Zhang, Shangzhi Xiong, et al.. (2025). A scoping review of Chinese national policies to promote the three-medicals linkage reform since 2014. 2(1). 1 indexed citations
3.
Dong, Wenlan, et al.. (2025). Glutathione-s-transferase regulates oxidative stress in Megalurothrips usitatus in response to environmental stress. Pesticide Biochemistry and Physiology. 208. 106299–106299. 2 indexed citations
4.
Xu, Tingling, Wenlan Dong, Jinli Liu, et al.. (2024). Disease burden of Parkinson's disease in China and its provinces from 1990 to 2021: findings from the global burden of disease study 2021. The Lancet Regional Health - Western Pacific. 46. 101078–101078. 50 indexed citations breakdown →
5.
Dong, Wenlan, Xiao Zhang, Shiwei Liu, et al.. (2024). Effect of the national integrated demonstration area for the prevention and control of noncommunicable diseases programme on behavioural risk factors in China: a synthetic difference-in-differences study. The Lancet Regional Health - Western Pacific. 50. 101167–101167. 1 indexed citations
6.
Xu, Tingling, H. J. Yang, Shicheng Yu, et al.. (2023). Comprehensive assessment of resources for prevention and control of chronic and non-communicable diseases in China: a cross-sectional study. BMJ Open. 13(7). e071407–e071407. 3 indexed citations
7.
Jiang, Yingying, Tingling Xu, Wenlan Dong, Cordia Chu, & Maigeng Zhou. (2022). Study on the death and disease burden caused by high sugar-sweetened beverages intake in China from 1990 to 2019. European Journal of Public Health. 32(5). 773–778. 17 indexed citations
9.
Wu, Aimin, Wenlan Dong, Xinying Zeng, et al.. (2021). Neck pain is the leading cause of disability burden in China: Findings from the Global Burden of Disease Study 2017. Annals of Translational Medicine. 9(9). 777–777. 8 indexed citations
10.
Xu, Tingling, Bingsong Wang, Hua Liu, et al.. (2020). Prevalence and causes of vision loss in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019. The Lancet Public Health. 5(12). e682–e691. 147 indexed citations
11.
Ren, Xinwen, Shicheng Yu, Wenlan Dong, et al.. (2020). Burden of depression in China, 1990–2017: Findings from the global burden of disease study 2017. Journal of Affective Disorders. 268. 95–101. 171 indexed citations
12.
Liu, Shiwei, Zhuo Chen, Wenlan Dong, et al.. (2020). Integrated multisectoral non-communicable disease prevention and control in China: A review of agencies and policies. Journal of Global Health. 10(2). 20304–20304. 9 indexed citations
13.
Wu, Aimin, Wenlan Dong, Shiwei Liu, et al.. (2018). The prevalence and years lived with disability caused by low back pain in China, 1990 to 2016: findings from the global burden of disease study 2016. Pain. 160(1). 237–245. 69 indexed citations
14.
Ji, Ning, et al.. (2018). [Disease burden for gynecological disease in China, 2016].. PubMed. 53(5). 313–318. 6 indexed citations
15.
Zeng, Xinying, Hui Guo, Yong Jiang, et al.. (2018). Burden of diabetes, hyperglycaemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease study. Diabetes & Metabolism. 45(3). 286–293. 113 indexed citations
16.
Jiang, Yingying, et al.. (2017). [On National Demonstration Areas: a cluster analysis].. PubMed. 38(4). 496–502. 2 indexed citations
17.
Dong, Wenlan, et al.. (2017). [The disease burden for low back pain in China, 1990 and 2013].. PubMed. 51(2). 132–136. 8 indexed citations
18.
Wang, Bingsong, Nathan Congdon, Rupert Bourne, et al.. (2017). Burden of vision loss associated with eye disease in China 19902020: findings from the Global Burden of Disease Study 2015. British Journal of Ophthalmology. 102(2). 220–224. 37 indexed citations
19.
Dong, Wenlan, et al.. (2016). Self-rated health and health-related quality of life among Chinese residents, China, 2010. Health and Quality of Life Outcomes. 14(1). 5–5. 13 indexed citations
20.
Jiang, Yingying, Wenlan Dong, Chunhua Zhang, et al.. (2014). [Evaluation on the status quo of self monitoring of blood glucose and self-efficacy of diabetes patients in community].. PubMed. 48(8). 710–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026